Mortality in hematological malignancy patients with acute respiratory failure, a Grrr-OH study


Acute respiratory failure (ARF) is the most frequent complication in patients with hematological malignancies and is associated with high morbidity and mortality. ARF etiologies are numerous, and despite extensivediagnostic workflow, some patients remain with undetermined ARF etiology.

This is a post‑hoc study of a prospective multicenter cohort performed on 1011 critically ill hematologi‑cal patients. Relationship between ARF etiology and hospital mortality was assessed using a multivariable regressionmodel adjusting for confounders.
This study included 604 patients with ARF. All patients underwent noninvasive diagnostic tests, and a bronchoscopy and bronchoalveolar lavage (BAL) was performed in 155 (25.6%). Definite diagnoses were classified intofour exclusive etiological categories: pneumonia (44.4%), non‑infectious diagnoses (32.6%), opportunistic infection(10.1%) and undetermined (12.9%), with corresponding hospital mortality rates of 40, 35, 55 and 59%, respectively.Overall hospital mortality was 42%. By multivariable analysis, factors associated with hospital mortality were invasivepulmonary aspergillosis (OR 7.57 (95% CI 3.06–21.62); p < 0.005), use of invasive mechanical ventilation (OR 1.65 (95%CI 1.07–2.55); p = 0.02), a SOFA score > 7 (OR 3.32 (95% CI 2.15–5.15); p < 0.005) and an undetermined ARF etiology (OR 2.92 (95% CI 1.71–5.07); p < 0.005).

In patients with hematological malignancies and ARF, up to 13% remain with undetermined ARF etiology despite comprehensive diagnostic workup. Undetermined ARF etiology is independently associated with hospital mortality. Studies to guide second‑line diagnostic strategies are warranted
Acute respiratory failure, Hematological malignancies, Outcome, Etiologies, Bronchoalveolar lavage, Diagnostic strategy
Last updated: 10/11/2016

Leave a Reply

Your email address will not be published. Required fields are marked *